(NDI). According to the FDA definitions, an NDI is any dietary ingredient that was not marketed in the U.S. as a dietary supplement before October 15, 1994. For NDI filing, manufacturers must submit a safety dossier that details not just the ingredient’s safety profile, but also its intended use and supporting scientific evidence. The primary goal of the dossier is to convince FDA officials of the ingredient’s safety for the intended use.

As highlighted in the FDA’s guidance documents, particularly the “Dietary Supplements: New Dietary Ingredient Notifications and Related Issues” document, the safety determination can be based on a variety of factors, primarily focused on toxicology data, but also inclusive of historical use data and published research. These aspects significantly enhance the likelihood of a successful NDI notification.

Step 1: Compilation of Relevant Literature

To develop a strong new dietary ingredient notification safety dossier, the first crucial step is to compile relevant published literature. This literature should encompass peer-reviewed studies, clinical trials, and other scientific data that showcase safety, efficacy, and historical use.

• Conduct a Comprehensive Literature Review: Utilize scientific databases such as PubMed, Google Scholar, and Scopus to search for studies related to the new dietary ingredient. Pay attention to studies detailing both acute and chronic exposure, particularly looking for evidence supporting safety in human populations.
• Focus on Quality over Quantity: Aim to select studies that are methodologically sound and relevant to the safety profile of the ingredient. Prioritize publications that provide conclusive results backing the ingredient’s safe consumption.
• Examine Existing NDI Notifications: Reviewing previously submitted NDIs could set benchmarks for the type of data that FDA reviewers find acceptable.

Step 2: Assess Historical Use and Safety Data

The history of use is critical when developing a safety dossier. Historical use refers to the ingredient’s consumption patterns and safety profile when used in dietary supplements or food products. The data should span various demographics and regional markets to build a thorough case.

• Document Long-term Usage: If the ingredient has been used in traditional medicine or dietary supplements outside of the U.S., document these cases as part of your dossier. This includes noting consumption methods, dosages, and any reported adverse reactions.
• Survey the Global Market: Ingredients widely used in markets both within and outside the U.S. often have more substantial historical evidence supporting their safety. Regulatory submissions from the EU or other countries can serve as useful comparisons.

Step 3: Compile Toxicology Data

Toxicology data is a cornerstone of the NDI verification process. It offers insights into the ingredient’s potential adverse effects and helps establish a safety threshold. Depending on the ingredient’s complexity, this may involve extensive testing.

• Understand FDA Safety Expectations: The FDA expects rigorous testing to determine the ingredient’s toxicity profile. This includes acute and chronic toxicity studies, reproductive studies, and genotoxicity assessments.
• Consider Existing Safety Studies: If toxicity data has been generated through existing studies or animal models, it can bolster the case for safety considerably. Presenting this data clearly can simplify the FDA’s review process.

Step 4: Drafting the NDI Safety Dossier

With all relevant literature gathered and safety data compiled, the next step is drafting the NDI safety dossier. The dossier must be clear, organized, and comprehensive, containing multiple sections to guide the FDA reviewer through your evidence.

• Executive Summary: Start with a concise overview of the ingredient, its intended use, and a summary of the safety data presented.
• Data Sections: Clearly delineate each section of the dossier: Literature Review, Historical Use, Toxicology Data, and Safety Assessment. Each subsection should detail methodologies and findings, referencing relevant studies accurately.
• References: Comprehensive referencing is crucial for transparency. Ensure you attribute all literature accurately to maintain the credibility of your dossier.

Step 5: Review and Submission Process

Before submitting your NDI notification to the FDA, a critical step is the internal review process. This should involve multiple stakeholders to ensure accuracy and completeness.

• Internal Review: Engage regulatory affairs, quality assurance, and subject matter experts to review the document. Each team can provide insights into different aspects of the dossier.
• Prepare for Queries: Anticipate questions from the FDA regarding safety concerns or data gaps. Preparing clear, concise answers can expedite the review process.
• Submit the Dossier: Once satisfied, submit your NDI notification formally through the FDA’s prescribed channels, ensuring all required documents are included.

Step 6: Engaging with the FDA post-Submission

After submission, engage proactively with the FDA. The review process may take some time, and maintain readiness to respond to any questions posed by the FDA regarding your NDI notification.

• Acknowledgment of Receipt: Upon submission, keep a record of the acknowledgment from the FDA, which indicates the start of the review timeline.
• Responding to Feedback: Act swiftly to address any safety or procedural concerns raised by the FDA. This is crucial to ensure your NDI filing is not delayed.

Best Practices for Future NDI Filings

The landscape of dietary ingredients will always be intertwined with evolving regulations and consumer expectations. By adhering to the outlined processes for NDI notifications, brands can position themselves competitively while ensuring compliance with FDA regulations.

• Staying Informed: Regularly review updates to FDA regulations and guidance documents regarding dietary supplements and NDI notifications. This will ensure your submissions are always based on the latest scientific knowledge and regulatory expectations.
• Continuous Education: Engage in ongoing education about toxicology, dietary ingredients, and marketing standards to effectively position your responses to both FDA requirements and consumer trends.
• Development of Strong Collaborations: Build relationships with research institutions and other stakeholders in the dietary supplement industry to strengthen your evidence base for future submissions.

In summary, leveraging published literature, assessing the history of use, and compiling rigorous toxicology data are fundamental components of a successful new dietary ingredient notification safety dossier. By following the outlined steps and maintaining an informed approach, manufacturers can provide robust evidence that meets FDA safety expectations, paving the way for successful NDI approvals.